EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis

被引:47
作者
Filippi, M
Rocca, MA
Arnold, DL
Bakshi, R
Barkhof, F
De Stefano, N
Fazekas, F
Frohman, E
Wolinsky, JS
机构
[1] Ist Sci San Raffaele, Dept Neurol, Neuroimaging Res Unit, I-20132 Milan, Italy
[2] Univ Osped San Raffaele, I-20132 Milan, Italy
[3] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada
[4] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurol,Partners MS Ctr,Ctr Neurol Imaging, Boston, MA USA
[5] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Radiol, Boston, MA USA
[6] Vrije Univ Amsterdam Med Ctr, Image Anal Ctr, Amsterdam, Netherlands
[7] Univ Siena, Inst Neurol Sci, I-53100 Siena, Italy
[8] Karl Frenzens Univ, Dept Neurol, Graz, Austria
[9] Univ Texas, SW Med Ctr, Dallas, TX USA
[10] Univ Texas, Hlth Sci Ctr, Dept Neurol, Houston, TX 77225 USA
关键词
diagnosis; MRI; multiple sclerosis; prognosis;
D O I
10.1111/j.1468-1331.2006.01543.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Magnetic resonance (MR)-based techniques are widely used for the assessment of patients with suspected and definite multiple sclerosis (MS). However, despite the publication of several position papers, which attempted to define the utility of MR techniques in the management of MS, their application in everyday clinical practice is still suboptimal. This is probably related, not only, to the fact that the majority of published guidelines focused on the optimization of MR technology in clinical trials, but also to the continuing development of modern, quantitative MR-based techniques, that have not as yet entered the clinical arena. The present report summarizes the conclusions of the 'EFNS Expert Panel of Neuroimaging of MS' on the application of conventional and non-conventional MR techniques to the clinical management of patients with MS. These guidelines are intended to assist in the use of conventional MRI for the diagnosis and longitudinal monitoring of patients with MS. In addition, they should provide a foundation for the development of more widespread but rational clinical applications of non-conventional MR-based techniques in studies of MS patients.
引用
收藏
页码:313 / 325
页数:13
相关论文
共 157 条
[1]   Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis - A randomized, double-blind, placebo-controlled trial [J].
Achiron, A ;
Kishner, T ;
Sarova-Pinhas, I ;
Raz, H ;
Faibel, M ;
Stern, Y ;
Lavie, M ;
Gurevich, M ;
Dolev, M ;
Magalashvili, D ;
Barak, Y .
ARCHIVES OF NEUROLOGY, 2004, 61 (10) :1515-1520
[2]   The use of magnetic resonance imaging in the diagnosis and long-term management of multiple sclerosis [J].
Bakshi, R ;
Hutton, GJ ;
Miller, JR ;
Radue, EW .
NEUROLOGY, 2004, 63 (11) :S3-S11
[3]   Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trials [J].
Barkhof, F ;
Filippi, M ;
Miller, DH ;
Tofts, P ;
Kappos, L ;
Thompson, AJ .
JOURNAL OF NEUROLOGY, 1997, 244 (02) :76-84
[4]   Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis [J].
Barkhof, F ;
Filippi, M ;
van Waesberghe, JH ;
Molyneux, P ;
Rovaris, M ;
Nijeholt, GLA ;
Tubridy, N ;
Miller, DH ;
Yousry, TA ;
Radue, EW ;
Adèr, HJ .
NEUROLOGY, 1997, 49 (06) :1682-1688
[5]   Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon β1a [J].
Barkhof, F ;
Rocca, M ;
Francis, G ;
van Waesberghe, JHTM ;
Uitdehaag, BMJ ;
Hommes, OR ;
Hartung, HP ;
Durelli, L ;
Edan, G ;
Fernández, O ;
Seeldrayers, P ;
Sorensen, P ;
Margrie, S ;
Rovaris, M ;
Comi, G ;
Filippi, M .
ANNALS OF NEUROLOGY, 2003, 53 (06) :718-724
[6]   Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis [J].
Barkhof, F ;
Filippi, M ;
Miller, DH ;
Scheltens, P ;
Campi, A ;
Polman, CH ;
Comi, G ;
Ader, HJ ;
Losseff, N ;
Valk, J .
BRAIN, 1997, 120 :2059-2069
[7]   T1 hypointense lesions in secondary progressive multiple sclerosis:: effect of interferon beta-1b treatment [J].
Barkhof, F ;
van Waesberghe, JHTM ;
Filippi, M ;
Yousry, T ;
Miller, DH ;
Hahn, D ;
Thompson, AJ ;
Kappos, L ;
Brex, P ;
Pozzilli, C ;
Polman, CH .
BRAIN, 2001, 124 :1396-1402
[8]  
Beck RW, 2003, ARCH OPHTHALMOL-CHIC, V121, P944
[9]  
Benedict RHB, 2005, AM J NEURORADIOL, V26, P1824
[10]   Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis [J].
Benedict, RHB ;
Carone, DA ;
Bakshi, R .
JOURNAL OF NEUROIMAGING, 2004, 14 (03) :36S-45S